Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

280 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
Winger EE, Reed JL. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2011 Oct;66(4):320-8. doi: 10.1111/j.1600-0897.2011.00992.x. Epub 2011 Feb 14. Am J Reprod Immunol. 2011. PMID: 21314851
Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
Winger EE, Reed JL. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2008 Jul;60(1):8-16. doi: 10.1111/j.1600-0897.2008.00585.x. Epub 2008 Apr 1. Am J Reprod Immunol. 2008. PMID: 18422811
Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF.
Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2009 Feb;61(2):113-20. doi: 10.1111/j.1600-0897.2008.00669.x. Epub 2008 Dec 3. Am J Reprod Immunol. 2009. PMID: 19055656
A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss.
Winger EE, Reed JL. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2009 Oct;62(4):253-60. doi: 10.1111/j.1600-0897.2009.00733.x. Epub 2009 Aug 24. Am J Reprod Immunol. 2009. PMID: 19703143
Response to Gerard Chaouat: Primum Non Nocera.
Winger EE, Reed JL. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2009 Dec;62(6):427. doi: 10.1111/j.1600-0897.2009.00746.x. Epub 2009 Oct 15. Am J Reprod Immunol. 2009. PMID: 19839981 No abstract available.
Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG.
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2011 Jun;65(6):610-8. doi: 10.1111/j.1600-0897.2010.00946.x. Epub 2011 Jan 12. Am J Reprod Immunol. 2011. PMID: 21223418
Birth defect rates in women using Adalimumab (Humira(®) ) to treat immunologic-based infertility in IVF patients.
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2011 Sep;66(3):237-41. doi: 10.1111/j.1600-0897.2011.00994.x. Epub 2011 Apr 19. Am J Reprod Immunol. 2011. PMID: 21501282
Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2011 Nov;66(5):394-403. doi: 10.1111/j.1600-0897.2011.01018.x. Epub 2011 May 30. Am J Reprod Immunol. 2011. PMID: 21623994
Intravenous immunoglobulin for repeated IVF failure and unexplained infertility.
Virro MR, Winger EE, Reed JL. Virro MR, et al. Among authors: reed jl. Am J Reprod Immunol. 2012 Sep;68(3):218-25. doi: 10.1111/j.1600-0897.2012.01169.x. Epub 2012 Jul 17. Am J Reprod Immunol. 2012. PMID: 22805355
Die-off ratio correlates with increased TNF-α:IL-10 ratio and decreased IVF success rates correctable with humira.
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Taranissi M. Winger EE, et al. Among authors: reed jl. Am J Reprod Immunol. 2012 Nov;68(5):428-37. doi: 10.1111/j.1600-0897.2012.01179.x. Epub 2012 Jul 30. Am J Reprod Immunol. 2012. PMID: 22845061
280 results
Jump to page
Feedback